Cycurion, Inc.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
19. Earnings Per Share
- EARNINGS PER SHARE
| Table 20.1: Details of Basic and Dilutive (Loss)/Earnings Per Share | ||||
|---|---|---|---|---|
| For the Three Months Ended | For the Nine Months Ended | |||
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | |
| Basic net (loss)/income per share: | ||||
| Numerator | ||||
| Net (loss)/income including non-controlling interests | $(3,240,017) | $116,093 | $(18,778,917) | $109,712 |
| Less: Net loss attributable to non-controlling interest | (116,700) | - | (218,359) | - |
| Net (loss)/income attributable to common stockholders - basic | (3,123,317) | 116,093 | (18,560,558) | 109,712 |
| Denominator | ||||
| Weighted average shares outstanding - basic | 1,965,285 | 498,941 | 1,252,543 | 498,941 |
| Basic net (loss)/income per share attributable to common stockholders | $(1.59) | $0.23 | $(14.82) | $0.22 |
| Diluted net (loss)/income per share: | ||||
| Numerator | ||||
| Net (loss)/income attributable to common stockholders - basic | $(3,123,317) | $116,093 | $(18,560,558) | $109,712 |
| Add back interest for subordinated convertible promissory note | 2,500 | 2,500 | 40,833 | 7,500 |
| Net (loss)/income attributable to common stockholders - diluted | $(3,120,817) | $118,593 | $(18,519,725) | $117,212 |
| Denominator | ||||
| Weighted average shares outstanding - basic | 1,965,285 | 498,941 | 1,252,543 | 498,941 |
| Weighted-average effect of potentially dilutive securities: | ||||
| Conversion of subordinated convertible promissory note | 3,333 | 57,884 | 3,333 | 57,884 |
| Conversion of Series A Convertible Preferred Stock | - | 70,203 | - | 70,203 |
| Conversion of Series B Convertible Preferred Stock | - | 200,000 | - | 175,203 |
| Exercise of investor and placement agent warrants | - | 292,806 | - | 292,806 |
| Weighted average shares outstanding - diluted | 1,968,618 | 1,119,834 | 1,255,876 | 1,095,037 |
| Dilutive net (loss)/income per share attributable to common stockholders | $(1.59) | $0.11 | $(14.75) | $0.11 |
| Table 20.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect | ||||
|---|---|---|---|---|
| For the Three Months Ended | For the Nine Months Ended | |||
| September 30, 2025 | September 30, 2024 | September 30, 2025 | September 30, 2024 | |
| Conversion of Series A Convertible Preferred Stock | 151,126 | - | 114,388 | 70,203 |
| Conversion of Series B Convertible Preferred Stock | 45 | - | 56,601 | 162,637 |
| Conversion of Series C Convertible Preferred Stock | 1,202 | - | 1,202 | - |
| Conversion of Series D Convertible Preferred Stock | 5,000 | - | 15,264 | - |
| Conversion of Series E Convertible Preferred Stock | 2 | - | 1 | - |
| Exercise of investor and placement agent warrants | 613,255 | - | 491,652 | 315,028 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.